Evidence suggests that LAG-3 signaling negatively regulates the activation, proliferation, and cytokine secretion of Th1 cells, mechanisms exploited by tumor cells to evade immune surveillance during carcinogenesis and metastasis. The gene discussed is LAG3; the disease is neoplasm.